Utah · Medicare Part D · 2027 preview
Medicare Part D Changes for 2027 in Utah: Read Your ANOC
The letter that arrives this month decides what your prescriptions cost next year. Here is what the numbers in it mean, using CMS's final 2027 figures.
The bottom line
- For 2027 the Part D deductible rises to $700 (from $615) and the out-of-pocket cap rises to $2,400 (from $2,100), per CMS's April 6, 2026 Rate Announcement.
- The national base premium is $41.33 for 2027, up from $38.99, the maximum 6% increase the law allows. CMS is also ending the stand-alone premium stabilization demonstration after 2026.
- 15 more drugs get negotiated prices on January 1, 2027, including Ozempic ($274 vs a $959 list price), Trelegy, Linzess, Breo, Tradjenta and Janumet.
- Your plan's Annual Notice of Change arrives in September. It shows your own 2027 premium, deductible, tiers and pharmacies. Changes can be made October 15 to December 7.
- 391,825 Utahns had Part D coverage in May 2026 (CMS). Every one of them gets this letter.
Sometime before the end of September, every Utah retiree with Medicare drug coverage gets an envelope from their plan. It is thick, it is titled Annual Notice of Change, and most of it gets set aside for a quieter week that never comes. This year the numbers inside are worth ten minutes, because the federal rules underneath every plan move more in 2027 than they did in 2026: a higher deductible, a higher spending cap, a higher base premium, the end of a program that had been holding stand-alone drug plan premiums down, and lower prices on fifteen widely used drugs. This article walks through each change using CMS's final published figures, then shows what to look for in your own letter.
What changes in Medicare Part D for 2027?
Two numbers in the standard Part D benefit reset every January, and CMS finalized the 2027 values on April 6, 2026. The deductible ceiling moves from $615 to $700. The annual out-of-pocket threshold, the point after which you pay nothing for covered drugs for the rest of the year, moves from $2,100 to $2,400. The benefit structure itself does not change: there is still no coverage gap, still no cost-sharing once you reach the cap, and the Manufacturer Discount Program still applies to brand-name drugs. CMS's Contract Year 2027 final rule, issued April 2, 2026, wrote those Inflation Reduction Act features into permanent regulation now that the temporary program-instruction authority has expired.
| Part D parameter | 2026 | 2027 | Change |
|---|---|---|---|
| Maximum deductible (standard benefit) | $615 | $700 | +$85 |
| Annual out-of-pocket cap | $2,100 | $2,400 | +$300 |
| National base beneficiary premium | $38.99 | $41.33 | +6.0% |
| National average monthly bid amount | — | $296.05 | — |
| Extra Help copay, income at or below 100% FPL (generic / brand) | $1.60 / $4.90 | $1.65 / $5.00 | +$0.05 / +$0.10 |
| Extra Help copay, income 100–150% FPL (generic / brand) | $5.10 / $12.65 | $5.80 / $14.40 | +$0.70 / +$1.75 |
| Stand-alone premium stabilization demonstration | In effect | Ended | — |
| Drugs with negotiated prices in effect | 10 | 25 | +15 |
Sources: CMS, Announcement of CY 2027 MA Capitation Rates and Part C and Part D Payment Policies, April 6, 2026, Attachment V Table V-2 — cms.gov (PDF); CMS, Medicare Part D 2027 National Average Monthly Bid Amount Information, July 28, 2026 — cms.gov; CMS, Negotiated Prices for Initial Price Applicability Year 2027 — cms.gov (PDF). FPL = federal poverty level.
Two things the table does not say. First, $700 and $2,400 are ceilings and thresholds under the defined standard benefit; your plan can charge a lower deductible, or none, and can exempt generic tiers from it, and many Utah plans do. Second, the base premium is not a premium anyone pays. It is the starting point in a formula, and the actual premium of a given plan in Salt Lake County or Washington County can be well above or below it. The number that matters to you is on page one of the ANOC.
Why is the cap going up if it is supposed to be a cap?
Because the law that created it also indexed it. The Inflation Reduction Act set the out-of-pocket threshold at $2,000 for 2025 and directed CMS to update it every year afterward by the “annual percentage increase” in average per-person spending on covered Part D drugs, rounding as the statute specifies. The same multiplier applies to the deductible. For 2027 CMS calculated that increase at 13.65%, made up of a 9.37% trend in 2026 drug spending plus a 3.92% revision to earlier estimates. Multiply $615 by 1.1365 and round and you get $700; do the same to $2,100 and you get $2,400.
That is worth understanding rather than resenting, because it tells you what to expect. The cap is a real protection: it turns an open-ended risk into a known annual maximum, which is exactly the kind of number a retirement budget can be built around. But it is a maximum that tracks national drug spending, and in a year when GLP-1 medications and specialty oncology drugs are pushing that spending up, the cap follows. A Utah couple who both take brand-name drugs should plan on a combined worst case of $4,800 in 2027, not $4,200, plus premiums.
Which drugs get negotiated prices on January 1, 2027?
The first ten negotiated prices, covering drugs such as Eliquis, Jardiance, Xarelto and Januvia, took effect on January 1, 2026. The second cycle adds fifteen more on January 1, 2027, and CMS reached agreement on every one of them. Between January and December 2024, about 5.3 million of the 53 million people with Part D filled at least one of these fifteen drugs, and together the drugs accounted for about 15% of all Part D gross drug costs that year. CMS estimates that, had the negotiated prices been in effect in 2024, net Medicare spending on these drugs would have been about 44% lower, roughly $12 billion, and that people with Part D will save an estimated $685 million out of pocket in 2027 under the standard benefit.
Discount of the 2027 negotiated price from the 2024 list price (30-day supply), eight most-used drugs of the fifteen. Source: CMS, Negotiated Prices for Initial Price Applicability Year 2027 — cms.gov (PDF).
| Drug | Commonly treats | 2027 negotiated price, 30 days | 2024 list price, 30 days | Part D users, 2024 |
|---|---|---|---|---|
| Ozempic; Rybelsus; Wegovy | Type 2 diabetes; cardiovascular disease; obesity | $274 | $959 | 2,282,000 |
| Trelegy Ellipta | Asthma; COPD | $175 | $654 | 1,269,000 |
| Linzess | Chronic constipation; IBS-C | $136 | $539 | 632,000 |
| Breo Ellipta | Asthma; COPD | $67 | $397 | 626,000 |
| Tradjenta | Type 2 diabetes | $78 | $488 | 274,000 |
| Janumet; Janumet XR | Type 2 diabetes | $80 | $526 | 239,000 |
| Vraylar | Bipolar I; depression; schizophrenia | $770 | $1,376 | 118,000 |
| Xifaxan | Hepatic encephalopathy; IBS-D | $1,000 | $2,696 | 105,000 |
| Xtandi | Prostate cancer | $7,004 | $13,480 | 35,000 |
| Otezla; Otezla XR | Plaque psoriasis; psoriatic arthritis | $1,650 | $4,722 | 31,000 |
| Austedo; Austedo XR | Huntington's chorea; tardive dyskinesia | $4,093 | $6,623 | 27,000 |
| Ofev | Idiopathic pulmonary fibrosis | $6,350 | $12,622 | 24,000 |
| Ibrance | Breast cancer | $7,871 | $15,741 | 16,000 |
| Calquence | CLL/SLL; mantle cell lymphoma | $8,600 | $14,228 | 15,000 |
| Pomalyst | Multiple myeloma; Kaposi sarcoma | $8,650 | $21,744 | 14,000 |
All fifteen second-cycle drugs. List price is the 2024 wholesale acquisition cost for a 30-day supply based on 2024 fills; user counts are rounded to the nearest thousand. Source: CMS, Negotiated Prices for Initial Price Applicability Year 2027 — cms.gov (PDF).
Read the price column with one caveat. The negotiated price is what the plan and Medicare pay the pharmacy; what you pay is still your plan's copay or coinsurance for that drug's tier. On a tier with a flat copay, the lower price may change nothing at the counter until you reach the cap, though it slows how fast you get there. On a coinsurance tier, 25% of $274 is a very different number from 25% of $959. The ANOC tells you which kind of tier each of your drugs sits on for 2027, which is why the letter and this list belong side by side.
What will the ANOC actually show a Utah retiree?
Medicare.gov's description is short: if you are in a Medicare plan, your plan sends a Plan Annual Notice of Change “each fall,” in September, and it “includes any changes in coverage, costs, and more that will be effective in January.” If yours has not arrived, contact the plan. Inside, four items carry nearly all of the money.
- The 2027 monthly premium. For stand-alone drug plans this is the year to look closely. In 2025 and 2026 CMS ran a voluntary Premium Stabilization Demonstration that limited how far a participating stand-alone plan's premium could rise from one year to the next. On July 28, 2026 CMS announced it will discontinue the demonstration at the end of 2026 “to return the program to operating under traditional market conditions in CY 2027.” Some plans' premiums will barely move; others were being held down and now are not. Neither is visible from the outside. It is visible on page one of your letter.
- The 2027 deductible. Anything up to $700 is allowed. Check whether your plan raised it and whether your generic tiers are exempt.
- Your drugs' tiers. A drug that moves from Tier 2 to Tier 3, or from a copay tier to a coinsurance tier, can cost more even in a year when Medicare negotiated its price down. The formulary changes section lists every move.
- Your pharmacy's status. Preferred-pharmacy networks change. If the pharmacy you use in Provo or Logan or St. George drops from preferred to standard, the same drug on the same tier costs more.
One item that is not in the letter but grows with it: the Part D late enrollment penalty. Medicare.gov calculates it as 1% of the national base beneficiary premium for every full month you went without creditable drug coverage after becoming eligible, rounded to the nearest ten cents and added to your premium for as long as you have Part D. Because the base premium rises to $41.33, the penalty rises with it: a 24-month gap costs about $9.40 a month in 2026 and about $9.90 a month in 2027. People who get Extra Help do not pay it. More in our guide to the Part D late enrollment penalty in Utah.
How many Utahns does this touch?
Sources: CMS, Medicare Monthly Enrollment, Utah statewide, May 2026 — data.cms.gov; CMS, “Medicare Open Enrollment in Utah, 2026” state fact sheet, September 26, 2025 — cms.gov (PDF).
Of Utah's 488,797 Medicare beneficiaries in May 2026, 391,825 had Part D drug coverage, about 80%. The split matters for what the ANOC will say. The 140,690 Utahns in a stand-alone drug plan, most of them pairing it with Original Medicare and a Medigap policy, are the ones whose premium was subject to the stabilization demonstration and who should read the 2027 premium line first. The 251,135 in a Medicare Advantage plan with drug coverage will see the Part D changes folded into a single letter alongside any medical copay, network and supplemental benefit changes; in 2026 Utah had 55 Medicare Advantage plans on offer, and CMS will publish the 2027 count with the landscape files in mid-to-late September.
For 2026, CMS counted 10 stand-alone drug plans available in Utah and reported that 13.85% of Utahns in a stand-alone plan get Extra Help. Across all Part D enrollees in the state, subtracting the 339,209 recorded without the Low-Income Subsidy from the 391,825 total suggests roughly 52,600 Utah beneficiaries receive it. If you are one of them, the deductible and cap above do not apply to you the same way; see the next section.
What changes if you have Extra Help?
The Low-Income Subsidy, which Medicare calls Extra Help, replaces the deductible and tier structure with fixed maximum copayments. For 2027 CMS set those at $1.65 for a generic and $5.00 for a brand for people with income at or below 100% of the federal poverty level, and $5.80 and $14.40 for people between 100% and 150% of the poverty level and for other full-subsidy enrollees. Those are up from $1.60/$4.90 and $5.10/$12.65 in 2026. Copays stop entirely at the out-of-pocket threshold, the deductible is $0, and there is no late enrollment penalty. Institutionalized beneficiaries and those receiving home and community-based services pay $0.
Extra Help enrollees also get something the ANOC does not advertise: the ability to change plans outside the fall window. If a plan's 2027 formulary drops a drug you take, you are not locked in until next October. Details, and the income and asset limits, are in our guide to Extra Help and the Medicare Savings Programs in Utah.
Six things to do between the letter and December 7
- Find the ANOC and write the date on it. Medicare Open Enrollment runs October 15 through December 7, 2026; a change you make in that window takes effect January 1, 2027. If you do nothing, your plan renews with the new numbers.
- Put your 2027 premium and deductible next to your 2026 ones. The two lines in the letter, side by side, on a sticky note. That is the entire first pass.
- Check each drug against the formulary changes and against the list of fifteen. A drug newly negotiated and moved to a coinsurance tier can end up cheaper. A drug moved to a higher copay tier can end up dearer, negotiation or not.
- Confirm your pharmacy is still preferred. This is the change Utah retirees most often miss, because the pharmacy itself never tells you.
- Run your actual drug list on Medicare Plan Finder after the 2027 plans post in October. Medicare.gov's Plan Finder prices every plan in your ZIP code against your specific prescriptions and pharmacy. Ten minutes with the real list beats an hour with the brochure.
- Decide whether to use the Medicare Prescription Payment Plan. It spreads your out-of-pocket drug costs across the calendar year in monthly bills from the plan instead of at the pharmacy. Medicare.gov is explicit that it “doesn't save you money or lower your drug costs”; it changes when you pay them. With a $2,400 cap, a January-to-December spread caps the monthly bill at roughly $200 for someone who would otherwise hit the cap early. Participation is voluntary and free of charge, and you opt in through your plan.
We will walk through the 2027 premium, deductible, tier and pharmacy changes in your letter with you, in plain English, with no pressure. Education, not advice. We do not offer every plan available in your area.
Talk to a planner →Frequently asked questions
What is the Medicare Part D out-of-pocket cap for 2027?
$2,400. CMS set the 2027 annual out-of-pocket threshold at $2,400 in the CY 2027 Rate Announcement, up from $2,100 in 2026 and $2,000 in 2025. Once your out-of-pocket spending on covered Part D drugs reaches that amount, you pay nothing more for covered drugs for the rest of the calendar year. The cap counts what you pay plus the manufacturer discounts on brand-name drugs, but not your monthly premium.
Why does the Part D cap go up every year if it is a cap?
Because the Inflation Reduction Act indexes it. The law set the cap at $2,000 for 2025 and requires CMS to adjust it each year by the annual percentage increase in average per-person Part D drug spending, then round. For 2027 that increase was 13.65%, which moved the deductible from $615 to $700 and the cap from $2,100 to $2,400. The cap will keep rising in years when drug spending rises.
What is the Part D deductible for 2027?
The maximum standard deductible is $700 for 2027, up from $615 in 2026. Plans can charge less, and many do, or exclude certain tiers such as generics from the deductible. The number your own plan will charge is printed in the Annual Notice of Change your plan sends in September.
Which drugs get lower negotiated Medicare prices in 2027?
Fifteen Part D drugs from the second negotiation cycle: Ozempic, Rybelsus and Wegovy; Trelegy Ellipta; Xtandi; Pomalyst; Ofev; Ibrance; Linzess; Calquence; Austedo and Austedo XR; Breo Ellipta; Xifaxan; Vraylar; Tradjenta; Janumet and Janumet XR; and Otezla. Their negotiated prices take effect January 1, 2027, joining the 10 drugs whose prices took effect January 1, 2026, for a total of 25. CMS estimates the 2027 prices would have saved 44%, about $12 billion, on 2024 net Medicare spending for these drugs.
When does the Annual Notice of Change arrive and what should I check?
Medicare.gov says your plan sends the Annual Notice of Change each fall, in September, listing every change in coverage and cost that takes effect in January. Check four things: the 2027 premium, the 2027 deductible, whether each of your drugs is still on the formulary and on the same tier, and whether your pharmacy is still preferred. If the letter does not arrive, contact your plan. Changes can be made during Medicare Open Enrollment, October 15 through December 7, 2026.
How many Utahns does this affect?
About 391,825 Utah Medicare beneficiaries had Part D drug coverage in May 2026 out of 488,797 total, according to CMS Medicare Monthly Enrollment data: 140,690 in stand-alone drug plans and 251,135 in Medicare Advantage plans with drug coverage. Roughly 52,600 of them receive the Low-Income Subsidy, also called Extra Help, which sets their 2027 copayments at $1.65 to $14.40 per prescription until they reach the cap.
Sources
- CMS — Announcement of Calendar Year (CY) 2027 Medicare Advantage Capitation Rates and Part C and Part D Payment Policies, April 6, 2026 (Attachment V: 2027 deductible $700, out-of-pocket threshold $2,400, 13.65% annual percentage increase, Low-Income Subsidy copayments): cms.gov — 2027 Rate Announcement (PDF)
- CMS — 2027 Medicare Advantage and Part D Rate Announcement fact sheet: cms.gov — fact sheet
- CMS — Medicare Part D 2027 National Average Monthly Bid Amount Information, July 28, 2026 (NAMBA $296.05, base beneficiary premium $41.33, end of the Premium Stabilization Demonstration, landscape release timing): cms.gov — 2027 bid information
- CMS — 2026 Medicare Part D Bid Information and Premium Stabilization Demonstration Parameters (2026 base premium $38.99): cms.gov — 2026 bid information
- CMS — Final CY 2026 Part D Redesign Program Instructions (2026 deductible $615, cap $2,100): cms.gov — CY 2026 redesign
- CMS — Contract Year 2027 Medicare Advantage and Part D Final Rule, April 2, 2026 (codifying the IRA benefit redesign for 2027 and beyond): cms.gov — CY 2027 final rule
- CMS — Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2027 (15 drugs, prices, users, savings estimates): cms.gov — negotiated prices 2027 (PDF)
- CMS — Selected Drugs and Negotiated Prices (program overview, 2026 and 2027 cycles): cms.gov — selected drugs
- Medicare.gov — Plan Annual Notice of Change (ANOC): sent each fall, in September: medicare.gov — ANOC
- Medicare.gov — Part D late enrollment penalty (1% of the base premium per uncovered month): medicare.gov — late enrollment penalty
- Medicare.gov — What's the Medicare Prescription Payment Plan?: medicare.gov — prescription payment plan
- CMS — Medicare Monthly Enrollment (Utah statewide totals, Part D, PDP, MA-PD and non-LIS counts, May 2026): data.cms.gov — monthly enrollment
- CMS — Medicare Open Enrollment in Utah, 2026, state-by-state fact sheet, September 26, 2025 (10 stand-alone plans, 13.85% Extra Help, 55 MA plans): cms.gov — 2026 landscape (PDF)
About this article. Written by the Utah Retirement Income Data Desk and reviewed by Brian Penner, Retirement income & long-term care planner. Educational only — not medical, financial, or legal advice. The 2027 figures above are CMS's final published parameters as of September 8, 2026; individual plan premiums, deductibles, formularies and pharmacy networks for 2027 are set by each plan and will be published with the CMS landscape files and on Medicare Plan Finder in October. Utah enrollment counts are derived from public CMS files and the Low-Income Subsidy figure is our own subtraction from those files. Verify current details with your plan, Medicare.gov, or 1-800-MEDICARE before you act. Utah Retirement Income is a licensed independent insurance agency (NPN 16493717) and is not a government agency; we are not connected with or endorsed by Medicare, the Centers for Medicare & Medicaid Services, the Social Security Administration, or any government program, and nothing here should be read as an endorsement by them. We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area; please contact Medicare.gov, 1-800-MEDICARE, or your State Health Insurance Assistance Program — in Utah, the Utah SHIP — to get information on all of your options. A $0-premium plan is not free; you still pay Part B premiums and cost-sharing. If you call or text us, you consent to be contacted at the number you provide about your options; message and data rates may apply, and you can opt out at any time by replying STOP.